Johnson & Johnson-Pfizer Inc. Drug Long Shot Against Alzheimer’s

When 70-year-old Bill Price signed on in 2006 to become one of the early testers of the Alzheimers drug bapineuzumab, he held high hopes the injections would stop the disease that was starting to clai…
Read the full story: BioSpace.com Featured News